Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucocorticoid use and metabolic risk in rheumatoid arthritis
NL-OMON31392Phase 4Withdrawn
- Sponsor
- University Medical Center Utrecht
- Start
- Nov 2007
- Countries
- 1
01
Overview
Phase 4, open-label trial in rheumatoid arthritis (RA) (2 arms), sponsored by University Medical Center Utrecht. Primary endpoints: Disease activity and Cardiovascular risk factors and metabolic syndrome / insulin resistance. Planned start Nov 2007; status: withdrawn.
02
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NL-OMON31392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON31392.